Point72 Asset Management, L.P.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,480,836
-$2,565,964 QoQ
Shares Held
106,535
-68.2% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $418,627,713 across 21 Drug Manufacturers - Specialty & Generic names. AMLX ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
149,303 | $88,533,692 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
974,210 | $73,893,828 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,318,555 | $68,156,107 | |
| 4 | HLN |
Haleon plc
|
6,574,038 | $65,806,120 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,130,507 | $34,050,870 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,958 | $30,862,127 | |
| 7 | VTRS |
Viatris Inc
|
1,777,181 | $24,009,715 | |
| 8 | ADCT |
ADC Therapeutics SA
|
3,382,129 | $12,682,983 |
All Filings in AMLX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,480,836 | 106,535 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,046,800 | 335,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,916,996 | 2,790,066 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $29,077,465 | 4,536,266 | Shares | Defined | 2025-08-14 | |
| 2025-06-24 | $30,240,514 | 4,717,709 | Shares | Sole | 2025-06-25 | |
| 2025-03-31 | $3,246,059 | 916,966 | Shares | Defined | 2025-07-21 | |
| 2025-01-13 | $15,328,658 | 4,820,333 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $648 | 200 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $482,800 | 170,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,499,209 | 2,751,305 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $842 | 46 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $153,297 | 7,107 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,529,632 | 324,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $78,628,122 | 2,127,960 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $13,144,952 | 466,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,017,998 | 312,461 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||